Overview

Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration

Status:
Completed
Trial end date:
2017-11-17
Target enrollment:
0
Participant gender:
All
Summary
A small percentage of patients with retinal degeneration accumulate fluid in the center of their retina. Previous studies using an oral form of treatment has been successful in decreasing this fluid which improves vision. This study will test the use of a topically applied form of this treatment to the eye to reduce the amount of fluid and improve or preserve vision.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Illinois at Chicago
Treatments:
Dorzolamide
Criteria
Inclusion Criteria:

- Presence of cystic macular fluid on OCT testing

Exclusion Criteria:

- Allergic reaction to sulpha containing compounds

- Intolerance to dorzolamide (Trusopt)